Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon May 12, 2019 1:20pm
143 Views
Post# 29739306

RE:RE:Opdivo Fails in Late Stage GBM trial

RE:RE:Opdivo Fails in Late Stage GBM trial
robertshaw wrote:
enriquesuave wrote: We need to start our trial ASAP. They are looking for alternatives. IMHO 
https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-announces-phase-3-checkmate-498-study-did


Maybe somebody could contact Bristol-Myers-Squibb to be a matchmaker for our technology, offer them 5% of the Tlt.v 's total holdings in exchange BMS' 10 billion Dollars for JV for curing GBM technology.


Several years ago, when I worked in ConocoPhillips oilsand Surmount project, ConocoPhillips is doing JV with Total oil company, for curing cancers' project, Tlt shouldn't just all go itself, better leave some money on the table for big players like BMS, doing JV is a better way, no matter 5% or 10%, just negotiate with all of the pharmaceutical companies, to maximize the benefits for both sides, and help to cure this deadly disease.
Bullboard Posts